Impact of bacterial resistance on antibiotic policy;IMPACTO DE LAS RESISTENCIAS BACTERIANAS SOBRE LA POLITICA ANTIBIOTICA

Medicina Intensiva

Volumn 22, Issue 1, 1998, Pages 17-23

  Alvarez Lerma F ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

Antibiotic policy; Bacterial resistance; Intensive Medicine Departments; Severely ill or critical patients

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; CRITICAL ILLNESS; DISEASE COURSE; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE; REVIEW;

EID: 0031892507     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Livermore DM. Mechanisms of resistance to B-lactam antibiotics. Scand J infect Dis 1991; 78 (Supp): 7-16.
2. Z. Bush K. Recent developments in B-lactamase research and their implications for the future. Rev Infect Dis 1988; 10:681-690.
3. Sanders Jr WE, Sanders CL. Inducible B-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 1988; 10:830-838.
4. Kosmidis J, Koratzanis G. Emergence of resistant bacterial strains during treatment of infections in the respiratory tract. Scan J Infect Dis 1986; 49(Supp):135-139.
5. Vogel F, Knothe H. Changes in aerobic faecal bacterial flora of severely ill patients during antibiotic treatment. Klin Wochenschc 1985; 63:1.174-1.179.
6. Quinn JP. Clinical significance of extendend spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13(Supp 1):39-42.
7. Meyer KS, Urban C, Egan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-358.
8. Rello J, Torres A, Ricart M, Valles J, González J, Artigas A, et al. Ventilator associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and meticillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150:1.545-1.549.
9. Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Domínguez MA, et al. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis 1996; 23:329-334.
10. Dworzak DL, Pugsley MP, Sanders CL, Horowitt EA. Emergence of resistance in Gram-negative bacteria during therapy with extended-spectrum cephalosporin. Eur J Clin Microbiol 1987; 6:456-459.
11. Phillips I. Prevalence and clinical importance of class I B-lactamases. Rev Infect Dis 1988; 10:839-847.
12. Finland M, Jones WF, Barnes MW. Occurrence of serious bacterial infections since introduction antibacterial agents. J Am Med Assoc 1959; 170:2.188-2.197.
13. Leeper MH, Moulton B, Dowling HD, Jackson GG, Kofman S. Epidemiology of erythromycin-resistant Staphylococci a hospital population. Effect on therapeutic activity of erythromycin. Antibiot Annu 1943-54. Medical Encyclopaedia Incorporated. New York: 1953:308-313.
14. Barber M, Dutton AAC, Beard MA, Elmes PC, Williams R. Reversal of antibiotic resistance in Hospital Staphylococcal infection. Br Med J 1970; 1:11-17.
15. Forbes I, Gray A, Hurse A, Pavillard R. Emergence of gentamicin-resistant Klebsiellae in a large general hospital. Med J Aust 1970; 1:14-16.
16. Cichon JJ, Craig CP, Sargent J, Brauner L. Nosocomial Klebsiella infections in an Intensive Care Nursey. South Med J 1977; 70:33-35.
17. Gamman W, Cates C, Snelling CFT, Lank B, Ronald AR. Emergence of gentamicin and carbenicilin-resistant Pseudomonas aeruginosa in a Hospital Environment. Antimicrob Agents Chemother 1976; 9:747-780.
18. Starkey DH, Gregory E. Fluctuations in antibiotic resistances of Gram-negative rods in one Hospital, 1961-1970 with comment on kanamycin-neomycin relationships. Can Med Assoc J 1971; 105:587-590.
19. Price DJ, Sleigh JD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet 1970; II:1.213-1.215.
20. Lowbury EJL, Babb JR, Roe E. Clearance from a hospital of Gram-negative bacilli that transfer-carbenicillin-resistance to Pseudomonas aeruginosa. Lancet 1972; II:941-945.
21. Bridges K, Lowbury EJL. Drug resistance in relation to use of silver sulphadizine cream in a burns unit. J Clin Pathol 1977; 30:160-164.
22. Feely TW, du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosol polymyxin and pneumonia in serious ill patients. N Engl J Med 1975; 293:471-475.
23. Webb CH. Antibiotic resistance associated with selective decontamination of the digestive tract. J Hosp Infect 1992; 22:1-5.
24. Nardi G, Valentinis U, Proietti A, de Monte A, di Silveste A, Muzzi R, et al. Epidemiological impact of prolonged systematic use of topical SDD on bacterial colonization of the tracheobronchial tree and antibiotic resistance. A three year study. Intensive Care Med 1993; 19:273-278.
25. Hammond JM, Potgieter PD. Long-term effects of selective decontamination on antimicrobial resistance. Crit Care Med 1995; 23:637-645.
26. Van Saene HKF, Stoutenbeek CP, Zandstra DF. Cefocaxime combined with selective decontamination in long term intensive care unit patients. Drugs 1988; 35:29-34.
27. Lizasoain M, Davila FM, Rubio J, Álvarez C, Perea S, Sanz F, et al. Acinetobacter baumanii multi-resistente incluido a carbapenems. Brote epidémico en UVI. Congreso Nacional de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Libra de programa y resúmenes, 1996; 2.
28. Snydmann DR. Clinical implications of multi-drug resistance in the intensive care unit. Scan J Infect Dis (supp 78) 1991; 54-63.
29. Álvarez-Lerma F and ICU-Acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996; 22:387-394.
30. Barriere SL, Lowry SF. An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393.
31. Insausti J, Álvarez-Lerma F, de la Cal MA, Palomar M, Olaecbea P y Grupo de Vigilancia de Infección Nosocomial en UCI. Características y evolución del consumo de antibióticos en Medicina Intensiva 1997; 21(Supll): 4.
32. Frieden TR, Munsiff SS, Low DE, Willey BM, Williams G. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993; 342:76-79.
33. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M, et al. Intestinal decontamination for control of nosocomial multi-resistant gram-negative bacilli. Ann Intern Med 1989; 110:873-883.
34. Chow JW. Enterobacter bacteriemia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115:585-589.